Fundraising Fox
🦊/Companies
Sign in

Psylink

4 known investors

Find your way into Psylink

Psilocybin biosynthesis platform that produces psychoactive molecular entities using yeast-based technology for pharmaceutical research and drug development.

BiotechDeep TechDigital Health

Founders & leadership

LM
Laura Martinkute KorsakovainCo-founder and CEO

Investors · 4

BSV VenturesVilnius · $5K – $430K
FirstpickVilnius · $110K – $550K
BSVreportedDallas
Coinvest Capitalreported · 2 sourcesVilnius · $55K – $580K

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Lithuania-Based BioTech Startup Psylink Raises Over €500K to Advance Nature-Inspired Mental Health Therapiesarabfounders.net · Jul 2025Coinvest Capital Leads Round for Psylink’s Next-Gen Biotech Solution for Mental Health Innovation | ILTEilte.lt · Jul 2025Lithuanian BioTech platform Psylink raises over €500k for mental health innovation | EU-Startupseu-startups.com · Jul 2025Lithuania’s Psylink raises pre-seed funding to advance sustainable psychedelic compound research - ArcticStartuparcticstartup.com · Jul 2025Psylink raises €501K to develop innovative treatments for mental healten.ain.ua · Jan 2014Press about BSV Ventures (formerly known as Baltic Sandbox Ventures) - BSV Venturesbsv.ventures

Frequently asked questions

What does Psylink do?
Psilocybin biosynthesis platform that produces psychoactive molecular entities using yeast-based technology for pharmaceutical research and drug development.
Who founded Psylink?
Psylink was founded by Laura Martinkute Korsakova.
Who are Psylink's investors?
Psylink's investors include BSV Ventures, Firstpick, BSV, Coinvest Capital.